Onglyza is a discontinued brand-name oral tablet. It contained the active ingredient saxagliptin and was used to treat type 2 diabetes. Onglyza was usually taken once per day. But it’s no longer ...
In a recent study published in PLOS Digital Health, researchers investigated the complexity of polypharmacy and whether frequent dose adjustments were required for co-medications and drug pairs in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results